Ultra-high purity surfactant for biologics and parenteral drug formulations
Relonchem receives marketing authorization for Moxonidine tablets
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
The entity will undertake the installation, operation, and maintenance of sewage treatment plants
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Subscribe To Our Newsletter & Stay Updated